[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Docetaxel Market in South Korea - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 91 pages | ID: DEF4417BBBBCEN
Market Monitor Global

US$ 2,700.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Docetaxel is a chemotherapy medication used to treat a number of types of Cancer. This includes breast Cancer, head and neck Cancer, stomach Cancer, Prostate Cancer and non-small-cell lung Cancer. It may be used by itself or along with other chemotherapy medication. It is given by slow injection into a vein.
This report contains market size and forecasts of Docetaxel in South Korea, including the following market information:
South Korea Docetaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
South Korea Docetaxel Market Consumption, 2015-2020, 2021-2026, (K Units)
South Korea Docetaxel Production Capacity, 2015-2020, 2021-2026, (K Units)
Top Five Competitors in South Korea Docetaxel Market 2019 (%)
The global Docetaxel market was valued at xx million in 2019 and is projected to reach US$ xx million by 2026, at a CAGR of xx% during the forecast period. While the Docetaxel market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Docetaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Docetaxel production and consumption in South Korea

Total Market by Segment:

South Korea Docetaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (K Units)
South Korea Docetaxel Market Segment Percentages, By Type, 2019 (%)
  • 20 mg/ml
  • 40 mg/ml
  • 60 mg/ml
South Korea Docetaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (K Units)
South Korea Docetaxel Market Segment Percentages, By Application, 2019 (%)
  • Breast Cancer
  • Prostate Cancer
  • Non-small Cell Lung Cancer
  • Other
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Docetaxel Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
Total Docetaxel Market Competitors Revenues Share in South Korea, by Players 2019 (%)
Total South Korea Docetaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (K Units)
Total South Korea Docetaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
  • Hengrui Medicine
  • Sanofi
  • Qilu Pharma
  • Shenzhen Main Luck Pharma
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Docetaxel Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 South Korea Docetaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: SOUTH KOREA DOCETAXEL OVERALL MARKET SIZE

2.1 South Korea Docetaxel Market Size: 2020 VS 2026
2.2 South Korea Docetaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 South Korea Docetaxel Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Docetaxel Players in South Korea (including Foreign and Local Companies)
3.2 Top South Korea Docetaxel Companies Ranked by Revenue
3.3 South Korea Docetaxel Revenue by Companies (including Foreign and Local Companies)
3.4 South Korea Docetaxel Sales by Companies (including Foreign and Local Companies)
3.5 South Korea Docetaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Docetaxel Companies in South Korea, by Revenue in 2019
3.7 South Korea Manufacturers Docetaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Docetaxel Players in South Korea
  3.8.1 List of South Korea Tier 1 Docetaxel Companies
  3.8.2 List of South Korea Tier 2 and Tier 3 Docetaxel Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - South Korea Docetaxel Market Size Markets, 2020 & 2026
  4.1.2 20 mg/ml
  4.1.3 40 mg/ml
  4.1.4 60 mg/ml
4.2 By Type - South Korea Docetaxel Revenue & Forecasts
  4.2.1 By Type - South Korea Docetaxel Revenue, 2015-2020
  4.2.2 By Type - South Korea Docetaxel Revenue, 2021-2026
  4.2.3 By Type - South Korea Docetaxel Revenue Market Share, 2015-2026
4.3 By Type - South Korea Docetaxel Sales & Forecasts
  4.3.1 By Type - South Korea Docetaxel Sales, 2015-2020
  4.3.2 By Type - South Korea Docetaxel Sales, 2021-2026
  4.3.3 By Type - South Korea Docetaxel Sales Market Share, 2015-2026
4.4 By Type - South Korea Docetaxel Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - South Korea Docetaxel Market Size, 2020 & 2026
  5.1.2 Breast Cancer
  5.1.3 Prostate Cancer
  5.1.4 Non-small Cell Lung Cancer
  5.1.5 Other
5.2 By Application - South Korea Docetaxel Revenue & Forecasts
  5.2.1 By Application - South Korea Docetaxel Revenue, 2015-2020
  5.2.2 By Application - South Korea Docetaxel Revenue, 2021-2026
  5.2.3 By Application - South Korea Docetaxel Revenue Market Share, 2015-2026
5.3 By Application - South Korea Docetaxel Sales & Forecasts
  5.3.1 By Application - South Korea Docetaxel Sales, 2015-2020
  5.3.2 By Application - South Korea Docetaxel Sales, 2021-2026
  5.3.3 By Application - South Korea Docetaxel Sales Market Share, 2015-2026
5.4 By Application - South Korea Docetaxel Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Hengrui Medicine
  6.1.1 Hengrui Medicine Corporate Summary
  6.1.2 Hengrui Medicine Business Overview
  6.1.3 Hengrui Medicine Docetaxel Major Product Offerings
  6.1.4 Hengrui Medicine Sales and Revenue in South Korea (2015-2020)
  6.1.5 Hengrui Medicine Key News
6.2 Sanofi
  6.2.1 Sanofi Corporate Summary
  6.2.2 Sanofi Business Overview
  6.2.3 Sanofi Docetaxel Major Product Offerings
  6.2.4 Sanofi Sales and Revenue in South Korea (2015-2020)
  6.2.5 Sanofi Key News
6.3 Qilu Pharma
  6.3.1 Qilu Pharma Corporate Summary
  6.3.2 Qilu Pharma Business Overview
  6.3.3 Qilu Pharma Docetaxel Major Product Offerings
  6.3.4 Qilu Pharma Sales and Revenue in South Korea (2015-2020)
  6.3.5 Qilu Pharma Key News
6.4 Shenzhen Main Luck Pharma
  6.4.1 Shenzhen Main Luck Pharma Corporate Summary
  6.4.2 Shenzhen Main Luck Pharma Business Overview
  6.4.3 Shenzhen Main Luck Pharma Docetaxel Major Product Offerings
  6.4.4 Shenzhen Main Luck Pharma Sales and Revenue in South Korea (2015-2020)
  6.4.5 Shenzhen Main Luck Pharma Key News
6.5 Jiangsu Aosaikang Pharma
  6.5.1 Jiangsu Aosaikang Pharma Corporate Summary
  6.5.2 Jiangsu Aosaikang Pharma Business Overview
  6.5.3 Jiangsu Aosaikang Pharma Docetaxel Major Product Offerings
  6.5.4 Jiangsu Aosaikang Pharma Sales and Revenue in South Korea (2015-2020)
  6.5.5 Jiangsu Aosaikang Pharma Key News

7 DOCETAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Docetaxel Production Capacity and Value in South Korea, Situation Analysis and Prediction, 2015-2026
  7.1.1 South Korea Docetaxel Production Capacity, 2015-2026
  7.1.2 South Korea Docetaxel Production 2015-2026
  7.1.3 South Korea Docetaxel Production Value 2015-2026
7.2 Key Local Docetaxel Manufacturers in South Korea
  7.2.1 South Korea Key Local Docetaxel Manufacturers Production Capacity
  7.2.2 South Korea Key Local Docetaxel Manufacturers Production
  7.2.3 South Korea Key Local Docetaxel Manufacturers Production Value
  7.2.4 The Proportion of Docetaxel Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
7.3 Docetaxel Export and Import in South Korea
  7.3.1 South Korea Docetaxel Export Market
  7.3.2 South Korea Docetaxel Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for South Korea Docetaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON DOCETAXEL SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Docetaxel Distributors and Sales Agents in South Korea

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Docetaxel in South Korea
Table 2. Top Players in South Korea, Ranking by Revenue (2019)
Table 3. South Korea Docetaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. South Korea Docetaxel Revenue Share by Companies, 2015-2020
Table 5. South Korea Docetaxel Sales by Companies, (K Units), 2015-2020
Table 6. South Korea Docetaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Docetaxel Price (2015-2020) (USD/Unit)
Table 8. South Korea Manufacturers Docetaxel Product Type
Table 9. List of South Korea Tier 1 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of South Korea Tier 2 and Tier 3 Docetaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Docetaxel Revenue in South Korea (US$, Mn), 2015-2020
Table 12. By Type - Docetaxel Revenue in South Korea (US$, Mn), 2021-2026
Table 13. By Type - Docetaxel Sales in South Korea (K Units), 2015-2020
Table 14. By Type - Docetaxel Sales in South Korea (K Units), 2021-2026
Table 15. By Application - Docetaxel Revenue in South Korea, (US$, Mn), 2015-2020
Table 16. By Application - Docetaxel Revenue in South Korea, (US$, Mn), 2021-2026
Table 17. By Application - Docetaxel Sales in South Korea, (K Units), 2015-2020
Table 18. By Application - Docetaxel Sales in South Korea, (K Units), 2021-2026
Table 19. Hengrui Medicine Corporate Summary
Table 20. Hengrui Medicine Docetaxel Product Offerings
Table 21. Hengrui Medicine Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Sanofi Corporate Summary
Table 23. Sanofi Docetaxel Product Offerings
Table 24. Sanofi Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Qilu Pharma Corporate Summary
Table 26. Qilu Pharma Docetaxel Product Offerings
Table 27. Qilu Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Shenzhen Main Luck Pharma Corporate Summary
Table 29. Shenzhen Main Luck Pharma Docetaxel Product Offerings
Table 30. Shenzhen Main Luck Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Jiangsu Aosaikang Pharma Corporate Summary
Table 32. Jiangsu Aosaikang Pharma Docetaxel Product Offerings
Table 33. Jiangsu Aosaikang Pharma Docetaxel Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Docetaxel Production Capacity (K Units) of Local Manufacturers in South Korea, 2015-2020
Table 35. Docetaxel Production (K Units) of Local Manufacturers in South Korea, 2015-2020
Table 36. South Korea Docetaxel Production Market Share of Local Manufacturers, 2015-2020
Table 37. Docetaxel Production Value (US$, Mn) of Local Manufacturers in South Korea, 2015-2020
Table 38. South Korea Docetaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 39. The Percentage of Docetaxel Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 40. The Percentage of Docetaxel Production Sold in South Korea and Sold Other Than South Korea by Manufacturers
Table 41. Dangeguojia Docetaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 42. Raw Materials and Suppliers
Table 43. Docetaxel Downstream Clients in South Korea
Table 44. Docetaxel Distributors and Sales Agents in South Korea

LIST OF FIGURES

Figure 1. Docetaxel Segment by Type
Figure 2. Docetaxel Segment by Application
Figure 3. Dangeguojia Docetaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Docetaxel Market Size in South Korea, (US$, Mn) & (K Units): 2020 VS 2026
Figure 6. South Korea Docetaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Docetaxel Sales in South Korea: 2015-2026 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Docetaxel Revenue in 2019
Figure 9. By Type - South Korea Docetaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - South Korea Docetaxel Market Share, 2015-2020
Figure 11. By Type - South Korea Docetaxel Market Share, 2020-2026
Figure 12. By Type - South Korea Docetaxel Price (USD/Unit), 2015-2026
Figure 13. By Application - Docetaxel Revenue in South Korea (US$, Mn), 2020 & 2026
Figure 14. By Application - South Korea Docetaxel Market Share, 2015-2020
Figure 15. By Application - South Korea Docetaxel Market Share, 2020-2026
Figure 16. By Application -South Korea Docetaxel Price (USD/Unit), 2015-2026
Figure 17. South Korea Docetaxel Production Capacity (K Units), 2015-2026
Figure 18. South Korea Docetaxel Actual Output (K Units), 2015-2026
Figure 19. South Korea Docetaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of South Korea Docetaxel Export Destination, 2019
Figure 21. The Source of Imports of South Korea Docetaxel, 2019
Figure 22. PEST Analysis for South Korea Docetaxel Market in 2020
Figure 23. Docetaxel Market Opportunities & Trends in South Korea
Figure 24. Docetaxel Market Drivers in South Korea
Figure 25. Docetaxel Market Restraints in South Korea
Figure 26. Docetaxel Industry Value Chain


More Publications